SEC Tracker
Get the app
NMTC · XBRL financial data

NeuroOne Medical Technologies financial statements, every quarter

The same tables from 13 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (NMTC's year ends in late September)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025†Mar 31, 2026Jun 30, 2026
Revenue742*9781,377826272*3,2741,3871,6962,741*2,8931,8621,973
Cost of revenue548*711987544131*1,3476157811,212*1,325872790
Gross profit194*266390282141*1,9277719151,529*1,5689901,183
Research and development1,779*1,4831,2741,1951,114*1,1721,5111,1821,118*1,3901,4681,425
Selling, general and administrative1,579*2,1732,0031,8811,844*2,0431,9401,6191,782*1,8851,9192,182
General and administrative————year only1,6541,5821,2651,347*1,4541,5041,693
Total operating expenses3,358*3,6573,2773,0762,958*3,2163,4512,8012,900*3,2753,3873,607
Operating income (loss)(3,165)*(3,390)(2,886)(2,794)(2,817)*1,711(2,680)(1,887)(1,371)*(1,707)(2,397)(2,424)
Other income (expense)30*46312622*919—————
Net income (loss)(3,135)*(3,345)(2,855)(2,768)(3,351)*1,785(2,271)(1,501)(1,619)*(1,438)(2,382)(2,006)
Earnings per share, basic USD per share(0.14)*(0.14)(0.11)(0.10)(0.11)*0.06(0.07)(0.03)(0.03)*(0.03)(0.28)(0.23)
Earnings per share, diluted USD per share(0.14)*(0.14)(0.11)(0.10)(0.11)*0.06(0.07)(0.03)(0.03)*(0.03)(0.28)(0.28)
Weighted average shares, basic thousands of shares22,217*23,99625,91027,35329,788*30,83831,11248,60549,953*50,3318,4858,662
Weighted average shares, diluted thousands of shares22,217*23,99625,91027,35329,788*30,88031,11248,60549,910*50,3318,4858,740
  • † Share count changed about 1/6 in the period ending 2026-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (NMTC's year ends in late September)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025†Mar 31, 2026Jun 30, 2026
Cash and cash equivalents5,3222,6812,4351,6201,4601,1341,3208,0406,5703,5622,8042,048
Accounts receivable—5435564111772,369319—1,2652,6621,8971,099
Inventory1,7271,6091,3121,7932,6351,9311,8351,8982,2271,6662,0992,290
Prepaid and other current assets264260408261216195——————
Total current assets7,3135,0934,7104,0854,6315,7123,75410,17110,2268,0677,1075,789
Property and equipment, net526505496472417382335315259245231202
Right-of-use asset169140111282255339312284255226197167
Total assets8,0975,8225,3954,9135,3706,4944,45710,81910,7868,5787,5696,186
Accounts payable6857607817591,0297459114681,010552934906
Accrued liabilities1,1086237609321,1848268539581,2937067551,136
Total current liabilities1,7931,3831,5401,6912,2131,5711,7631,4262,3031,2581,6892,041
Lease liability, non-current5521—2101942372071751431109273
Total liabilities1,8481,4041,5401,9014,5483,5593,3312,6423,7132,1762,4912,419
Accumulated deficit(62,686)(66,031)(68,886)(71,654)(75,004)(73,219)(75,490)(76,991)(78,610)(80,048)(82,430)(84,436)
Total stockholders' equity6,2494,4183,8543,0128222,9351,1268,1777,0736,4025,0773,768
Total liabilities and equity8,0975,8225,3954,9135,3706,4944,45710,81910,7868,5787,5696,186
Common shares outstanding (cover page) thousands of shares23,96325,93127,51630,81230,84230,86349,81850,00050,41350,5268,6209,106
  • † Share count changed about 1/6 in the period ending 2026-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (NMTC's year ends in late September)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025†Mar 31, 2026Jun 30, 2026
Net income (loss)(3,135)*(3,345)(2,855)(2,768)(3,351)*1,785(2,271)(1,501)(1,619)*(1,438)(2,382)(2,006)
Stock-based compensation271*309357*339*340*339250*317*359*359342*353*
Depreciation and amortization63*———————————
Net cash from operating activities(2,903)*(3,809)(2,175)*(2,360)*(2,667)*208(56)*(1,464)*(1,526)*(3,116)(1,329)*(1,082)*
Purchases of property and equipment58*3731*15*37*243*44*11*4139*20*
Net cash from investing activities(50)*(37)(31)*(15)*(37)*(24)(3)*(44)*(11)*(41)(39)*(20)*
Proceeds from issuing common stock0*1,2562,0941,6830*——9,200*———359*
Net cash from financing activities5,192*1,2051,960*1,561*2,544*(509)245*8,226*67*148610*345*
  • † Share count changed about 1/6 in the period ending 2026-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Neuroone Medical Technologies2,0481,973(1,082)*9.1M1.9 quarters 10-QJun 30, 2026
Precision Optics9,8418,774*(649)*11.0M15.2 quarters 10-KJun 30, 2026
United Health Products240(138)*262.7M0.2 quarters 10-QJun 30, 2026
RenovoRx9,479909(2,867)*45.1M3.3 quarters 10-QJun 30, 2026
Nephros4,6976,017681*10.9M— 10-QJun 30, 2026
electroCore8,5019,450(3,518)*9.0M2.9 quarters 10-QJun 30, 2026
DarioHealth6,634not reported(6,083)*9.8M2.3 quarters 10-QJun 30, 2026
Vivos Therapeutics1,7745,153(3,148)*20.1M0.6 quarters 10-QJun 30, 2026
Positron357112(1,050)*32.8M0.3 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.